Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Lupus ; 18(1): 38-43, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19074167

RESUMEN

Menstrual cycles of 30 patients with juvenile systemic lupus erythematosus (JSLE) were compared with 30 age-matched controls. The mean age of patients with JSLE and controls was similar (17.4 +/- 3.2 vs 17.06 +/- 2.08 years, P = 0.66). The mean menarche age was higher in JSLE than controls (13.13 +/- 1.4 vs 11.56 +/- 1.5 years, P = 0.0008). On the contrary, the mean maternal menarche age was similar in both groups (P = 0.62). Menstrual abnormalities and longer length cycles were more frequently observed in JSLE than controls (63% vs 10%, P = 0.0001; 23% vs 0%, P = 0.0105, respectively). The median of follicle stimulating hormone was significantly higher in patients with JSLE compared with controls (4.6 vs 3.4 IU/L, P = 0.0207), and the median of progesterone was lower (32.5 vs 70 ng/mL, P = 0.0033). The median of luteinizing hormone was lower in patients with JSLE with menstrual abnormalities versus normal cycles (2.9 vs 5.5 IU/L, P = 0.019) and both had a high percentage of decreased progesterone levels (63% vs 73%, P = 0.70). Our findings support the notion that menstrual disturbances are frequent and may be associated with pituitary dysfunction leading to a decreased progesterone production. We also reported that in spite of premature ovarian failure being a rare event in JSLE the follicular reserve seems to be low regardless of intravenous cyclophosphamide treatment.


Asunto(s)
Hormona Folículo Estimulante/sangre , Lupus Eritematoso Sistémico/fisiopatología , Ciclo Menstrual/metabolismo , Progesterona/sangre , Adolescente , Brasil/epidemiología , Estudios de Casos y Controles , Niño , Ciclofosfamida/uso terapéutico , Femenino , Humanos , Inmunosupresores/uso terapéutico , Hormona Luteinizante/sangre , Menarquia/fisiología , Enfermedades de la Hipófisis/etiología , Enfermedades de la Hipófisis/fisiopatología , Adulto Joven
2.
Lupus ; 16(6): 430-5, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17664234

RESUMEN

To evaluate cervicovaginal cytology in adolescents with juvenile systemic lupus erythematosus (JSLE) and to compare them to controls. Fifty-two female adolescents with JSLE (ACR criteria) were compared to 52 age-matched healthy controls. All Pap smears were evaluated by the same cytopathologist blinded to gynecology examination (Bethesda 2001). The mean age of JSLE patients and controls were similar (16.17 +/- 1.94 versus 16.13 +/- 2.16 years, P = 0.92). The cervicovaginal cytology was found to be similar in both groups, although sexual intercourses in the last month were less frequent in JSLE than controls (23% versus 59.6%, P = 0.0003). Only one patient (2%) with JSLE versus two controls (4%) had cervical dysplasia (LGSIL) and human papilomavirus (P = 1.0). Candida spp vaginitis was observed in seven JSLE (14%) versus none in controls (P = 0.012) and was associated with immunosuppressive drugs (P = 0.01) and high dose of prednisone (P = 0.002). Of interest, inflammatory cervicovaginal cytology was observed in 21 (60%) of patients with SLEDAI > or = 4 and only four (23%) of those with SLEDAI < 4 (P = 0.001). Likewise, a higher frequency of inflammatory changes was also observed in virgin JSLE (57% versus 8%, P = 0.005). Our findings supports the notion that female genital tract may be a potential target organ in SLE since cervical inflammation is associated to disease activity independently of sexual activity.


Asunto(s)
Cuello del Útero/patología , Lupus Eritematoso Sistémico/patología , Lupus Eritematoso Sistémico/fisiopatología , Vagina/patología , Adolescente , Candidiasis , Niño , Condiloma Acuminado/complicaciones , Condiloma Acuminado/diagnóstico , Femenino , Humanos , Inflamación/patología , Lupus Eritematoso Sistémico/complicaciones , Prueba de Papanicolaou , Índice de Severidad de la Enfermedad , Vagina/microbiología , Vagina/virología , Frotis Vaginal , Vaginosis Bacteriana/complicaciones , Vaginosis Bacteriana/microbiología
3.
Lupus ; 11(7): 419-25, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12195782

RESUMEN

The authors analysed the gonadal function and age of menarche of 23 female adolescents and young women with SLE, and correlated these with clinical, SLEDAI and therapeutic parameters. The presence of one or more clinical and laboratory parameters defined normal gonadal function: normal menstrual cycles with or without dysmenorrhea; elevated cervical mucus length; normal levels of plasma FSH, LH, estradiol, progesterone, prolactin and testosterone; normal urinary hormonal cytology; serial pelvic ultrasound compatible with ovulatory pattern; and present or previous pregnancy. The mean age of menarche (13.5 +/- 1.4 years) was greater than that found among 2578 healthy Brazilian adolescents (12.5 +/- 1.3 years; P = 0.0002). The delay in menarche correlated with an increase in the duration of the disease (P = 0.0085) and the cumulative dose of prednisone (P = 0.0013) used until the appearance of the menarche. The mean phase length in SLE was 31.5 +/- 10.3. Sixteen female (70%) patients showed normal and seven (30%) abnormal gonadal function. Gonadal function was not correlated with parameters of SLE. These results suggest that the patients of this study reach adulthood with a high chance of fertility.


Asunto(s)
Dismenorrea/complicaciones , Dismenorrea/fisiopatología , Lupus Eritematoso Sistémico/complicaciones , Menarquia/fisiología , Ciclo Menstrual/fisiología , Adolescente , Adulto , Factores de Edad , Femenino , Hormonas Esteroides Gonadales/sangre , Humanos , Ovario/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA